Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02496208 |
Title | Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination With Ipilimumab (CaboNivoIpi) in Patients With Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
Los Angeles General Medical Center | Los Angeles | California | 90033 | United States | Details | |
USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | United States | Details | |
NCI - Center for Cancer Research | Bethesda | Maryland | 20892 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details |